Introduction
Amphetamine mixed salts, commonly known by the brand name Adderall, are a widely prescribed medication for Attention Deficit Hyperactivity Disorder (ADHD) and certain cases of narcolepsy. The NDC code 00406-8892 corresponds to the 10 mg immediate-release tablet formulation of amphetamine mixed salts manufactured by Mallinckrodt. Here, we will delve into the market analysis and price projections for this specific formulation.
Market Dynamics
Competition in the Prescription Drug Market
The prescription drug market, particularly for ADHD medications, is characterized by a mix of branded and generic products. According to the ASPE report, drugs with fewer manufacturers tend to have higher prices, while those with multiple manufacturers see more competitive pricing[3].
For amphetamine mixed salts, there are several generic versions available, including those from Alvogen, Granules, and Mallinckrodt, among others. This competition can influence pricing, as generic drugs often offer more affordable alternatives to branded products.
Drug Expenditures and Prescriptions
From 2017 to 2022, total inflation-adjusted expenditures on prescription drugs increased by 18.4%, with a significant rise in spending on biological products. However, spending on small molecule drugs, such as amphetamine mixed salts, remained relatively flat during this period, indicating a drop in price per prescription[3].
Pricing Trends
Historical Pricing
The prices of amphetamine mixed salts have been subject to fluctuations based on market competition and regulatory factors. Generic versions of the drug have helped keep prices in check. For instance, the average cost of small molecule drugs, which include amphetamine mixed salts, was around $48 per prescription in 2022, significantly lower than biological products[3].
Current Pricing
As of the latest data, the prices for amphetamine mixed salts immediate-release tablets vary by manufacturer and dosage strength. For the 10 mg tablet (NDC: 00406-8892), prices can range from approximately $10 to $30 per unit, depending on the pharmacy, location, and insurance coverage.
Price Projections
Impact of Competition
Given the presence of multiple generic manufacturers, the prices for amphetamine mixed salts are likely to remain competitive. As more generic versions enter the market, the pricing pressure is expected to continue, potentially leading to slight decreases in the average cost per prescription.
Regulatory and Policy Changes
Policy changes and regulatory oversight can significantly impact drug pricing. For example, increased scrutiny on drug prices and potential policy changes aimed at reducing healthcare costs could further influence the pricing of amphetamine mixed salts[2].
Technological Advancements
The use of AI in drug discovery and development, as predicted for 2025, could lead to more efficient and cost-effective production methods. However, this is more likely to impact the development of new drugs rather than the pricing of existing medications like amphetamine mixed salts[5].
Supply Chain and Availability
Drug Shortages
Drug shortages can significantly impact pricing due to supply and demand imbalances. As of recent reports, there have been no widespread shortages of amphetamine mixed salts, which helps maintain stable pricing. However, any future shortages could lead to temporary price increases[4].
Key Takeaways
- Competition: The presence of multiple generic manufacturers keeps prices competitive.
- Pricing Trends: Prices for small molecule drugs like amphetamine mixed salts have remained relatively stable or decreased slightly due to increased competition.
- Regulatory Impact: Policy changes and regulatory oversight can influence pricing.
- Supply Chain: Stable supply chains currently support stable pricing, but shortages could impact prices.
FAQs
-
What is the current price range for amphetamine mixed salts 10 mg immediate-release tablets?
- The current price range can vary from approximately $10 to $30 per unit, depending on the pharmacy, location, and insurance coverage.
-
How does competition affect the pricing of amphetamine mixed salts?
- Competition from multiple generic manufacturers helps keep prices competitive and can lead to slight decreases in the average cost per prescription.
-
What are the potential impacts of regulatory changes on drug pricing?
- Regulatory changes aimed at reducing healthcare costs could further influence the pricing of amphetamine mixed salts, potentially leading to lower prices.
-
Can AI in drug discovery affect the pricing of existing medications like amphetamine mixed salts?
- AI is more likely to impact the development of new drugs rather than the pricing of existing medications like amphetamine mixed salts.
-
How do drug shortages affect the pricing of amphetamine mixed salts?
- Drug shortages can lead to temporary price increases due to supply and demand imbalances, but current reports indicate no widespread shortages.
Sources
- DailyMed: MIXED SALTS OF A SINGLE ENTITY AMPHETAMINE PRODUCT XR[1]
- PwC: Next in pharma 2024: Reinventing for returns[2]
- ASPE: Competition in Prescription Drug Markets, 2017-2022[3]
- ASHP: Amphetamine Mixed Salts, Immediate-Release Tablets[4]
- Lewis Silkin LLP: Life Sciences – Trends and predictions for 2025[5]